TrialEuropean journal of nuclear medicine and molecular imaging2019

Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.

Maja Guberina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.